These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17998053)

  • 1. Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation.
    Camici GG; Stallmach T; Hermann M; Hassink R; Doevendans P; Grenacher B; Hirschy A; Vogel J; Lüscher TF; Ruschitzka F; Gassmann M
    Methods Enzymol; 2007; 435():147-55. PubMed ID: 17998053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin.
    Wiessner C; Allegrini PR; Ekatodramis D; Jewell UR; Stallmach T; Gassmann M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):857-64. PubMed ID: 11435798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin pretreatment attenuates myocardial infarct size: a possible mechanism involves heat shock Protein 70 and attenuation of nuclear factor-kappaB.
    Xu B; Dong GH; Liu H; Wang YQ; Wu HW; Jing H
    Ann Clin Lab Sci; 2005; 35(2):161-8. PubMed ID: 15943180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion.
    French CJ; Zaman AK; Sobel BE
    Coron Artery Dis; 2009 Jun; 20(4):295-9. PubMed ID: 19440068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM; Jia Z; Zhou ZQ; Xu JG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose erythropoietin has no long-term protective effects in sheep with reperfused myocardial infarction.
    Olea FD; Vera Janavel G; De Lorenzi A; Cuniberti L; Yannarelli G; Cabeza Meckert P; Cearras M; Laguens R; Crottogini A
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):736-41. PubMed ID: 16810073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experimental study of recombinant human erythropoietin on the treatment of acute myocardial infarction in rats].
    Ye L; Du XL; Xia JH; Jiang P; Wang JT; Fan HM; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2776-80. PubMed ID: 17199998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.
    Moon C; Krawczyk M; Ahn D; Ahmet I; Paik D; Lakatta EG; Talan MI
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11612-7. PubMed ID: 14500913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
    Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
    Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury.
    Roubille F; Combes S; Leal-Sanchez J; Barrère C; Cransac F; Sportouch-Dukhan C; Gahide G; Serre I; Kupfer E; Richard S; Hueber AO; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2007 Dec; 116(23):2709-17. PubMed ID: 18025529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow.
    Quinn J; Fisher PW; Capocasale RJ; Achuthanandam R; Kam M; Bugelski PJ; Hrebien L
    Cytometry A; 2007 Aug; 71(8):612-24. PubMed ID: 17542025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction in the C57BL/6J mouse: a quantifiable and highly reproducible experimental model.
    Salto-Tellez M; Yung Lim S; El-Oakley RM; Tang TP; ALmsherqi ZA; Lim SK
    Cardiovasc Pathol; 2004; 13(2):91-7. PubMed ID: 15033158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MRL mouse repairs both cryogenic and ischemic myocardial infarcts with scar.
    Grisel P; Meinhardt A; Lehr HA; Kappenberger L; Barrandon Y; Vassalli G
    Cardiovasc Pathol; 2008; 17(1):14-22. PubMed ID: 18160056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic erythropoietin treatment decreases post-infarct myocardial damage in rats without venous thrombogenic effect.
    Prunier F; Pottier P; Clairand R; Mercier A; Hajjar RJ; Planchon B; Furber A
    Cardiology; 2009; 112(2):129-34. PubMed ID: 18596374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rate of right ventricular infarction after ligation of mid left anterior descending artery in rats.
    Samsamshariat SA; Movahed MR
    Cardiovasc Revasc Med; 2005; 6(1):21-3. PubMed ID: 16263352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
    Rao Y; Wang YL; Zhang WS; Liu J
    Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.
    Abbate A; Salloum FN; Vecile E; Das A; Hoke NN; Straino S; Biondi-Zoccai GG; Houser JE; Qureshi IZ; Ownby ED; Gustini E; Biasucci LM; Severino A; Capogrossi MC; Vetrovec GW; Crea F; Baldi A; Kukreja RC; Dobrina A
    Circulation; 2008 May; 117(20):2670-83. PubMed ID: 18474815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model for an erythropoietin-deficiency anemia.
    Zeigler BM; Vajdos J; Qin W; Loverro L; Niss K
    Dis Model Mech; 2010; 3(11-12):763-72. PubMed ID: 20959632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction.
    Wagner KD; Wagner N; Bondke A; Nafz B; Flemming B; Theres H; Scholz H
    FASEB J; 2002 Jul; 16(9):1117-9. PubMed ID: 12039855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion.
    Salloum FN; Hoke NN; Seropian IM; Varma A; Ownby ED; Houser JE; Van Tassell BW; Abbate A
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):495-8. PubMed ID: 19455055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.